The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor

[1]  J. Koutcher,et al.  Metabolic Signatures Associated with a NAD Synthesis Inhibitor–Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance Spectroscopy , 2005, Clinical Cancer Research.

[2]  R. Swanson,et al.  Poly(ADP-ribose) Polymerase-1-mediated Cell Death in Astrocytes Requires NAD+ Depletion and Mitochondrial Permeability Transition* , 2004, Journal of Biological Chemistry.

[3]  B. Rattel,et al.  Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma. , 2003, Anticancer research.

[4]  Max Hasmann,et al.  FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. , 2003, Cancer research.

[5]  Simon C Watkins,et al.  Intra-mitochondrial Poly(ADP-ribosylation) Contributes to NAD+ Depletion and Cell Death Induced by Oxidative Stress* , 2003, The Journal of Biological Chemistry.

[6]  B. Rattel,et al.  WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells. , 2002, Cancer research.

[7]  M. Nakagawa,et al.  Depletion of intracellular NAD(+) and ATP levels during ricin-induced apoptosis through the specific ribosomal inactivation results in the cytolysis of U937 cells. , 2000, Journal of biochemistry.

[8]  G. Schwartz,et al.  Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascade. , 1997, Oncology research.

[9]  H. Kolb,et al.  DNA-damage and NAD(+)-depletion are initial events in oxygen radical induced islet cell death. , 1997, Advances in experimental medicine and biology.

[10]  G. Cohen,et al.  NAD+ depletion and cytotoxicity in isolated hepatocytes. , 1988, Biochemical pharmacology.

[11]  L. Hurley,et al.  Depletion of nicotinamide adenine dinucleotide in normal and xeroderma pigmentosum fibroblast cells by the antitumor drug CC-1065. , 1986, Biochemistry.

[12]  F. Althaus,et al.  Poly(ADP-ribose) biosynthesis and suicidal NAD+ depletion following carcinogen exposure of mammalian cells. , 1986, Biochemical and biophysical research communications.

[13]  R. Bredehorst,et al.  DNA fragmentation and NAD depletion. Their relation to the turnover of endogenous mono(ADP-ribosyl) and poly(ADP-ribosyl) proteins. , 1982, The Journal of biological chemistry.

[14]  A. Miller,et al.  Reporting results of cancer treatment , 1981, Cancer.